Skip to menu Skip to content Skip to footer

The development of DMX8.1 as a novel treatment for immunotherapy-refractory cancers (2024-2026)

Experts

Associate Professor Jason Lee

Principal Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Jason Lee

Associate Professor Arutha Kulasinghe

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Principal Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Arutha Kulasinghe
Arutha Kulasinghe